Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aruba Aloë Formula F-BC-096 is a topical, medical-grade aloe-based formulation developed through a collaboration between Royal Aruba Aloe and the burn clinic at Ghent University Hospital (University Hospital, Ghent). It is specifically designed for the treatment and hydration of scars, particularly split thickness donor sites following wound closure in burn patients. The formulation aims to improve scar characteristics such as hydration, elasticity, and color while minimizing redness. Although it was the subject of a prospective, randomized, double-blinded controlled clinical trial to evaluate its efficacy against control products, the trial was ultimately withdrawn.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aruba Aloë Formula F-BC-096.